Novezza Pharma Private Limited - Due diligence report
A 360° intelligence report on Novezza Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and …
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Novezza Pharma Private Limited — 360° Intelligence Report
Generated from MCA filings & public recordsNovezza Pharma Private Limited is assessed as Low Risk with a Trust Score of 76/100. Novezza Pharma Private Limited is an active private limited indian non-government company incorporated in 2015, operating in the Healthcare sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a moderate compliance risk and an unassessed financial risk profile.
Report generated on 10 Oct 2026 from the latest processed filings. Novezza Pharma Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
No processed financialsCredit & Compliance Intelligence
Why the scores are what they are- Financial statements needed for a credit view.
Charges position: 2 open (1.16 cr) · 0 satisfied (-).
| Lender | Charges | Amount |
|---|---|---|
| Vijaya Bank | 1 | 48.0 cr |
| Others | 1 | 48.0 cr |
- Company status is Active as per MCA.
- Marked ACTIVE non-compliant (INC-22A).
- No balance-sheet filing date on record.
- 2 active GST registration(s).
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| RUPINDER KAUR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BALWANT SINGH BEDI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- BALWANT SINGH BEDI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- No distress signals on file.
- No financials on record - ask for audited statements.
- No filed financials - rely on banking statements and GST data.
- 2 open charge(s) of 1.16 cr already registered.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management churn warrants questions.
MCA Filings & Events Timeline
Latest 7 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| QUIQR HR SERVICES LLP | AAG-3224 | Patiala, Punjab |
| Amydus Health Sciences Private Limited | U24290PB2020PTC050955 | Patiala, Punjab |
| Krimo Vacations Private Limited | U63030PB2022PTC057229 | Patiala, Punjab |
| Offshore Mates Outsourcing Solutions Private Limited | U69201PB2023PTC059884 | Patiala, Punjab |
| Aquartis Innovations Private Limited | U29309PB2018PTC048268 | Patiala, Punjab |
| Innata Consumer Care Private Limited | U51909PB2021PTC054426 | Patiala, Punjab |
| RAJBIR REALTORS LLP | AAN-9937 | Patiala, Punjab |
| Genence Naturals Private Limited | U51909PB2018PTC048780 | Patiala, Punjab |
| REGNANT ACROSS LLP | AAJ-5870 | Patiala, Punjab |
| Dietyog Healthcare Services Private Limited | U85100PB2022PTC055282 | Patiala, Punjab |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Novezza Pharma Private Limited before audits and certifications: compliance score 70/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Novezza Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Novezza Pharma Private Limited - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 76/100, distress signals and MSME payment-delay disclosures - know whether Novezza Pharma Private Limited pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Novezza Pharma Private Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Novezza Pharma Private Limited an active company?
Novezza Pharma Private Limited has MCA status “Active” with a compliance score of 70/100 (Moderate).
Is Novezza Pharma Private Limited financially healthy?
Processed financial statements are not yet available for Novezza Pharma Private Limited, so its financial health is unassessed.
Should I do business with Novezza Pharma Private Limited?
Its overall Trust Score is 76/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Novezza Pharma Private Limited?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Novezza Pharma Private Limited have loans or charges against its assets?
2 open charge(s) are registered against its assets.
Is Novezza Pharma Private Limited up to date with its ROC filings?
Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 70/100 (Moderate).
Is it risky to lend to Novezza Pharma Private Limited?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.